Fig. 4
From: High expression of RIPK2 is associated with Taxol resistance in serous ovarian cancer
RIPK2 genomic alterations in ovarian cancer (cBioPortal). A OncoPrint of RIPK2 alterations in TCGA-OV cohort. Different types of genetic alterations are highlighted in different colors. B the relationship of copy number alterations and mRNA expression of RIPK2. C difference of genetic mutations in RIPK2 altered and unaltered group. Tumor protein p53 (TP53), BReast CAncer gene 1 (BRCA1), BReast CAncer gene 2 (BRCA2) and 10 other genes with the most significant p values were shown. D copy-number change. 10 genes with the most significant p values were shown. *p < 0.01